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Tuesday, February 15, 2022
During this COVID-19 pandemic and other future events, the CDM has been and will continue
to be a source of reliable information, education and models for mitigation, preparedness,
response and recovery. We hope this informational document has helped provide you filtered
and actionable information. As the pace of new information and changes occur, we will
evaluate the current once per week to determine if this information should be provided on a
more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

413,307,484

5,825,680

10,222,672,400

United States

77,919,113

922,474

544,563,895

New Jersey

2,146,285

32,399

16,350,427

New York

4,888,634

66,554

37,337,094

Connecticut

714,408

10,260

7,220,234

Information as of 2/15/22 at 0000 EST. Source: https://coronavirus.jhu.edu/map.html
United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continuing to partner with local organizations such as Westchester Department of
Emergency Services and Westchester Medical Center to ensure ongoing collaboration with
all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.

•
•
•
•
•

Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.
On February 7, 2020, CDC assistant director George W. Contreras, MEP, MPH, MS, CEM
was invited guest speaker at NYU Rory Meyers College of Nursing undergraduate
program. He presented a special lecture entitled “Nursing and Disasters” which discussed
the importance of interdisciplinary collaboration among public health, disaster medicine and
nursing.

The White House
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location.
https://www.whitehouse.gov
Health and Human Services (HHS)
•

The HHS, through the Health Resources and Services Administration (HRSA), awarded
nearly $55 million to 29 HRSA-funded health centers to increase health care access and
quality for underserved populations through virtual care such as telehealth, remote
patient monitoring, digital patient tools, and health information technology platforms. This
funding builds on over $7.3 billion in American Rescue Plan funding invested in
community health centers over the past year to help mitigate the impact of COVID-19.
“Virtual care has been a game-changer for patients, especially during the pandemic,”
said HHS Secretary Xavier Becerra. “This funding will help health centers leverage the
latest technology and innovations to expand access to quality primary care for
underserved communities. Today’s announcement reflects the Biden-Harris
Administration’s commitment to advancing health equity and putting essential health
care within reach for all Americans.” In response to the COVID-19 pandemic, health
centers have quickly expanded their use of virtual care to maintain access to essential
primary care services. They reported significant growth in the number of virtual visits
from 478,333 in 2019 to 28,550,608 in 2020, a remarkable 6,000 percent increase. In
total, the number of health centers offering virtual visits grew from 592 in 2019 to 1,362
in 2022, an increase of 130 percent. These new awards will enable health centers to
sustain an expanded level of virtual care and identify and implement new digital
strategies. https://www.hhs.gov/about/news/2022/02/14/hhs-awards-nearly-55-millionincrease-virtual-health-care-access-quality-through-community-health-centers.html

•

As part of the Biden-Harris Administration’s commitment to ensuring Americans who get
sick with COVID-19 have access to treatments that work, HHS Secretary Xavier Becerra
is announcing that the federal government has purchased 600,000 treatment courses of
a new monoclonal antibody treatment that data shows can work against the Omicron
variant. The new monoclonal antibody treatment, bebtelovimab, is manufactured by Eli
Lilly and Company, and if it receives emergency use authorization (EUA) by the U.S.
Food and Drug Administration (FDA), HHS will make the treatment available to states
free of charge. “Under President Biden’s leadership, we are prepared for the challenges
we face with COVID-19 and are laser-focused on saving lives,” said Secretary Becerra.
“We have more COVID-19 treatments than ever before, we are providing a billion free
at-home tests, and we have enough vaccines to get everyone vaccinated and boosted. If
authorized by FDA, this purchase will add an additional 600,000 courses of treatment to

our nation’s ‘medicine cabinet’ that could help prevent severe outcomes for Americans
who do get sick with COVID-19. Our top priority is preventing people from getting sick in
the first place, which is why it is critical that Americans continue to get vaccinated and
get their booster shot as soon as they’re eligible.” HHS would receive approximately
300,000 treatment courses of this monoclonal antibody in February and approximately
300,000 treatment courses in March. Recently, it was determined that data shows that
two monoclonal antibody treatments – one made by Lilly (bamlanivimab/etesevimab),
and one made by Regeneron (REGEN-COV) – are highly unlikely to work against
Omicron, which currently is estimated to make up about 100 percent of all COVID-19
cases in the U.S. Early data suggests that this new product by Lilly has activity against
both Omicron and the BA.2 Omicron subvariant. Should the BA.2 subvariant grow in
proportion in the U.S., this potential treatment may help ensure that we can continue to
offer monoclonal antibody treatment that works against that strain of the virus.
https://www.hhs.gov/about/news/2022/02/10/secretary-becerra-announces-hhspurchase-600000-treatment-courses-new-monoclonal-antibody-that-works-againstomicron.html
•

The HHS through the Health Resources and Services Administration (HRSA), is
providing $66.5 million in American Rescue Plan funding to eight grantees to expand
outreach efforts in 38 states and the District of Columbia to increase COVID-19 vaccine
confidence and vaccinations. “Building vaccine confidence is critical to increasing
vaccinations, which remains so important as we encourage boosters and kids’
vaccinations,” said HHS Secretary Xavier Becerra. This investment by the Biden-Harris
Administration further expands our progress in partnering with trusted local messengers
to deliver needed information on COVID-19 vaccines. This funding will help even more
community-based organizations build confidence in the COVID-19 vaccine among
people in their community who may not have been vaccinated yet.” With the addition of
today’s awards, HHS has provided a total of nearly $390 million to 158 organizations for
the Community-based Workforce for COVID-19 Vaccine Program, supporting outreach,
events, translation and other enabling services, education, and community health worker
support in underserved areas in all 50 states. Many of today’s recipients are continuing
to make progress in building vaccine confidence in diverse communities across the
country. They are supporting trusted messengers through partnering with Historically
Black Colleges and Universities (HBCUs), churches, and local community-based
organizations. https://www.hhs.gov/about/news/2022/02/08/hhs-provides-66-5-millionexpand-community-based-outreach-efforts-increase-covid-19-vaccinations.html

For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
•

The FDA has been notified by Pfizer that new data have recently emerged
regarding its emergency use authorization request for the use of the PfizerBioNTech COVID-19 Vaccine in children 6 months through 4 years of age. As
part of its rolling submission, the company recently notified the agency of
additional findings from its ongoing clinical trial. Based on the agency’s
preliminary assessment, and to allow more time to evaluate additional data, we
believe additional information regarding the ongoing evaluation of a third dose
should be considered as part of our decision-making for potential
authorization. Therefore, the FDA is postponing the Vaccines and Related
Biological Products Advisory Committee meeting originally scheduled for Feb. 15.
This will give the agency time to consider the additional data, allowing for a
transparent public discussion as part of our usual scientific and regulatory
processes for COVID-19 vaccines. We will provide an update on timing for the
advisory committee meeting once we receive additional data on a third dose in
this age group from the company’s ongoing clinical trial and have an opportunity
to complete an updated evaluation. https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-postpones-advisory-committeemeeting-discuss-request-authorization

•

The FDA issued an emergency use authorization (EUA) for a new monoclonal
antibody for the treatment of COVID-19 that retains activity against the omicron
variant. The EUA for bebtelovimab is for the treatment of mild to moderate
COVID-19 in adults and pediatric patients (12 years of age and older weighing at
least 40 kilograms, which is about 88 pounds) with a positive COVID-19 test, and
who are at high risk for progression to severe COVID-19, including hospitalization
or death, and for whom alternative COVID-19 treatment options approved or
authorized by the FDA are not accessible or clinically appropriate. Bebtelovimab
is not authorized for patients who are hospitalized due to COVID-19 or require
oxygen therapy due to COVID-19. Treatment with bebtelovimab has not been
studied in patients hospitalized due to COVID-19. Monoclonal antibodies, such as
bebtelovimab, may be associated with worse clinical outcomes when
administered to hospitalized patients with COVID-19 requiring high flow oxygen or
mechanical ventilation. https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-new-monoclonalantibody-treatment-covid-19-retains

For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)

•

Data from two CDC reports today show COVID-19 vaccine boosters remain safe
and continue to be highly effective against severe disease over time. In the first
study, CDC reviewed data from two of its vaccine safety monitoring systems, vsafe and the Vaccine Adverse Event Reporting System (VAERS). They found that
people 18 years and older who received the same mRNA vaccine brand for all
their vaccinations experienced fewer adverse reactions following the booster
dose, than they did after their second dose of mRNA vaccine. Ninety two percent
(92%) of reports to VAERS were not considered serious, and headache, fever,
and muscle pain were among the most commonly reported reactions. V-safe data
found medical care was rarely received after a booster dose. A second study
reveals that a third dose of mRNA vaccine continues to offer high levels of
protection against severe disease, even months after administration,
underscoring the importance of staying up to date when eligible after receiving a
primary series. CDC examined data on 93,000 hospitalizations and 241,000
emergency department and urgent care visits across 10 states during the Delta
and Omicron waves. In the study, about 10% of people were boosted and over
50% of people hospitalized were over 65 years old. During Omicron, vaccine
effectiveness against hospitalization was 91% during the first two months after a
third dose and remained high, at 78%, four or more months after a third dose.
Boosters are safe and effective, and CDC continues to recommend everyone 5
and older remain up to date with recommended COVID-19 vaccinations, to
ensure optimal protection against hospitalizations and severe outcomes. For most
people, that means getting a booster dose 5 months after receiving an mRNA
vaccine or 2 months after receiving Johnson and Johnson’s Janssen vaccine.
CDC is continuing to closely monitor the effectiveness of COVID-19 vaccines to
help inform public health efforts.
https://www.cdc.gov/media/releases/2022/s0211-covid-19-boosters.html

CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Center for Medicare and Medicaid Services (CMS) +
On February 3, 2022, CMS announced that Biden-Harris Administration will cover
free Over-the-Counter COVID-19 tests through Medicare- As part of the Biden-Harris

Administration’s ongoing efforts to expand Americans’ access to free testing, people
in either Original Medicare or Medicare Advantage will be able to get over-thecounter COVID-19 tests at no cost starting in early spring. Under the new initiative,
Medicare beneficiaries will be able to access up to eight over-the-counter COVID-19
tests per month for free. Tests will be available through eligible pharmacies and other
participating entities. This policy will apply to COVID-19 over-the-counter tests
approved or authorized by the U.S. Food and Drug Administration (FDA).
https://www.cms.gov/newsroom/news-alert/biden-harris-administration-will-coverfree-over-counter-covid-19-tests-through-medicare
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 PM. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
• The New York State Department of Health (DOH) issued guidance on preordering Pfizer COVID-19 vaccine for children ages six months to 4 years. To
ensure efficient rollout of this vaccine supply once authorized, the Centers for
Disease Control and Prevention (CDC) is allowing pre-ordering of vaccines
starting today, February 9. The minimum ordering quantity for this product is 100
doses. It has the same storage requirements as other Pfizer formulations
currently available—10 weeks refrigerated or up to 9 months ultra-cold
temperature). Please place pre-orders for the Pfizer COVID-19 vaccine for ages 6
months through 4 years of age separate from other vaccine orders. Providers
should review the DOH guidance for additional details on ordering, administering,
and documentation of the vaccine for this population. https://www.gnyha.org/wpcontent/uploads/2021/10/NYSDOH-Pediatric-Pfizer-Ordering-Guidance.pdf
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html

CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 16 and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
• Higher Education
• A new report from the Campaign for College Opportunity, a Californiabased research and policy advocacy organization, highlights ongoing
equity gaps for Black and Latinx students pursuing higher education in
Los Angeles County. The report, released today, describes some notable
gains in Black and Latinx students’ access to college and their academic
outcomes. However, it also notes stubborn education disparities and
suggests the COVID-19 pandemic could “threaten to offset and undo
years of improvements for California’s high schools and community
colleges” in particular. Michele Siqueiros, president of the Campaign for
College Opportunity, said Los Angeles County is “the most populous,
most significant county” in California, so the report has broader
implications for the state. The county is home to about a third of the Black
and Latinx residents in the state, and California has the most Latinx
residents of any state and the fifth-largest Black population in the country.
https://www.insidehighered.com/news/2022/02/11/college-access-andoutcomes-among-black-and-latinx-angelenos
• “Less than half of the general public in six developed nations believes
that universities have been important in helping the world through the
COVID-19 pandemic, according to a global survey. While the success of
academic science in developing vaccines, treatments and strategies to
combat the virus has saved countless lives, results from a poll of just over

6,000 people suggest that the reputational benefits accruing to
universities through the pandemic may be limited. Universities are far
from surfing a wave of popularity linked to COVID-19–era innovations—
only 46 percent of the general public said universities were important in
tackling the pandemic, according to a study by the World 100 Reputation
Network, which polled at least 1,000 people each in Australia, Britain,
Canada, Japan, the Netherlands and the United States. A fifth of
respondents said universities had been “unimportant” in the global fight
against COVID-19, while 25 percent had no sense either way of how
higher education institutions had contributed.”
https://www.insidehighered.com/news/2022/02/10/public-doesnt-credituniversities-advances-against-covid-19
•

K-12
•

•

Clinical Trials

A bipartisan group of state legislators has proposed a $45 million bill to
fund a K-12 cybersecurity program in New Mexico, just weeks after a
ransomware attack forced Albuquerque Public Schools, the largest
district in the state, to close for two days in mid-January. The bill would
fund three full-time employees and the development of a cybersecurity
program for the state’s education technology infrastructure during fiscal
years 2023 through 2026. The program would include cybersecurity
insurance support, training for employees and students, and creation of a
response and recovery plan. Bill co-sponsor state Rep. Rebecca Dow
gave the bill little chance of passing as is, so she’s working in the
meantime on securing $9.5 million for cybersecurity within the FY23 state
appropriations bill. https://www.k12dive.com/news/new-mexico-reppushes-45m-k-12-cybersecurity-proposal/618796/
School district leaders are more concerned about the mental health of
students, teachers and principals than any other school issue, including
student engagement, student discipline, low attendance and dipping
enrollment, according to a RAND Corp. survey released Tuesday. Among
the 359 district and charter network leaders surveyed between October
and December, 40% of urban district leaders said they were concerned
about lower enrollment for reasons other than delayed kindergarten entry,
compared to 20% of rural and 11% of suburban district leaders, RAND
reported. Additionally, about 75% of district leaders said political
polarization over COVID-19 safety and vaccines limited their ability to
teach students in the 2021-22 school year. Four out of 10 district leaders
said polarization tied to critical race theory had presented the same
problem, the survey found. https://www.k12dive.com/news/enrollmentdecline-mental-health-top-school-leaders-concerns/618651/

To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul announced New York's new Winter Toolkit for the new phase of
the pandemic, aiming to keep New York safe, open and moving forward. The Winter
Toolkit focuses on five core areas: protecting the most vulnerable New
Yorkers, increasing vaccinations and boosters, strengthening our health care system,
empowering local leaders, and supporting individuals facing the long-term effects of
COVID. "As we begin a new phase in our response to this pandemic, my top priority is
making sure we keep New York safe, open and moving forward,"
Governor Hochul said. "I want to thank the health care workers, business owners and
everyday New Yorkers who acted responsibly during the Omicron surge by masking up
and getting vaccinated. But make no mistake: while we're moving in the right direction,
this pandemic isn't over and our new Winter Toolkit shows us the path forward."
https://www.governor.ny.gov/news/governor-hochul-announces-winter-toolkit-newphase-covid-response-keep-new-york-safe-open-and
• Governor Hochul held meetings with New York State teachers, superintendents and
parents to thank them for their work to keep our schools safe and open, and hear their
input on how to continue smartly protecting against COVID-19. "As we continue to see
cases and hospitalizations decline, I believe it is important to work closely with groups
and leaders on the ground so that we move forward in the pandemic in a way where we
can stay in front of COVID-19 and keep New Yorkers
safe," Governor Hochul said. "Keeping schools open has always been my top priority,
and I want to thank the teachers, administrators, and parents who joined me today to
hear directly from them. I want to also remind parents and guardians to please get their
children vaccinated and boosted, if eligible. The vaccine is safe, free, doctor-approved
and the key to keeping our communities and vulnerable loved ones safe."
https://www.governor.ny.gov/news/governor-hochul-holds-meetings-teachers-schoolsuperintendents-and-parents-discuss-pandemic
New York State Department of Health (DOH)
For a list of positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
• Governor Murphy signed Executive Order No. 288 which will extend the Public Health
Emergency declared on January 11, 2022 by Executive Order No. 280 for 30 days.
Governor Murphy’s intention to extend the Public Health Emergency was announced on
Monday, February 7, 2022. The Public Health Emergency allows the state to continue
vaccine distribution, vaccination or testing requirements in certain settings, the collection
of COVID-19 data, implementation of any applicable recommendations of the Centers
for Disease Control and Prevention to prevent or limit the transmission of COVID-19,
staffing and resource allocation, and other critical components of the State’s COVID-19
response. Under the Emergency Health Powers Act, the Public Health Emergency will
expire after 30 days, unless renewed. State COVID-19 metrics will be reevaluated at the
time of expiration to determine if an extension will be
needed. https://nj.gov/infobank/eo/056murphy/pdf/EO-288.pdf
Connecticut
• Bank of America today announced a $185,000 donation worth 370,000 meals to their
longtime partner, Connecticut Foodshare (formerly Connecticut Food Bank &
Foodshare), to help address food insecurity in the region. Bank of America
donated $100 for each bank employee who received a COVID-19 booster shot or
vaccine and notified the bank before the end of January. The company made an
additional contribution to address the increased need experienced by hunger relief
organizations across the country. According to Connecticut Foodshare, more than
428,000 people across the state, including 110,000 children, are food insecure. As the
pandemic continues, hunger relief organizations throughout Connecticut face ongoing
challenges due to increased demands for their services and rising food prices.
Connecticut Foodshare is seeing an increase of up to 40% on specific food items.
https://finance.yahoo.com/news/connecticut-foodshare-receives-185-000195800017.html

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
NYC DOHMH launched a new variants data page. The data on this page show how variants of the
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more
severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page
Westchester County Department of Health

For the latest breakdown of positive cases in Westchester County as of February 13, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of February 11, 2022
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of February 14, 2022
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of February 14, 2022
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
February 14, 2022
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Center for Disaster Medicine Media
Faculty News:
As Omicron Surges, Clear Guidelines are Needed for COVID-19 Testing
Visible Magazine
2/4/2022
https://visiblemagazine.com/as-omicron-surges-clear-guidelines-are-needed-for-covid-19testing/
John Loike, Ph.D., interim director of the Master of Science Degree and the Graduate
Certificate program in Bioethics, SHSP
No Giving It Short Shrift: COVID-19 Can Be a Long Haul
Managed Healthcare Executive
2/9/2022
https://www.managedhealthcareexecutive.com/view/no-giving-it-short-shrift-covid-19-can-bea-long-haul
Gary Rogg, M.D., assistant professor of medicine

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.

New York Medical College
Center for Disaster Medicine
7 Dana Road Suite 511
Valhalla, New York 10595
914-594-1750
https://www.nymc.edu/center-for-disaster-medicine/

